THE Therapeutic Goods
Administration has not received any
submissions to a consultation on
the proposed advisory statements
for Kunzea ambigua when included
in listed medicines for topical use.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 08 Apr 13 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Apr 13
PHARMACIES are likely to be offered a “little bit of leniency” as they go through the COVID-19 crisis, with banks viewing the sector positively, Medici Valuations Director, Christian Sirianni, believes.